title: Partial characterization of glioma-derived growth factor 2: a novel mitogenic activity from human cell line D-54 MG.
abstract: We have shown that several human malignant glioma cell lines are stimulated by bacterial lipopolysaccharide (E. coli 0111:B4, 1 microgram/ml) to produce a high molecular weight (> 200 kD) growth activity for BALB 3T3, clone A31 cells. This glioma-derived growth factor (GDGF-2) acts like a 'competence' factor. Malignant glioma cell line D-54 MG constitutively produced GDGF-2, which we have partially characterized from serum-free conditioned culture medium. GDGF-2 is resistant to heat (100 degrees C, 5 min), acidic (pH 2, 2 hr) or reducing (0.5 M 2 ME, 30 min) conditions as well as exposure to RNases; however, it is sensitive to > 4 freeze-thaw cycles, alkaline (pH 11, 2 hr) conditions or pre-treatment with proteolytic enzymes. GDGF-2 had a pl of 6.8 determined by preparative isoelectric focusing, bound to DEAE, with elution at 35 and 185 mM NaCl and at 43% acetonitrile from a C4 reversed phase column. GDGF-2 activity was not neutralized by antibodies to TGF alpha, TGF beta, PDGF, VEGF or TNF alpha indicating that it is not immunochemically related to these growth factors. However GDGF-2 co-chromatographed on Superose 12 HPLC (250 x 9 mm; 5% isopropanol, 6 mM CHAPS in PBS) with a substance that suppressed growth of mink lung epithelial cells (Mv1Lu), but not BALB 3T3 cells, and could be neutralized by anti-TGF beta antibodies. GDGF-2 activity eluted from heparin columns in 0.6 M NaCl; thus, it is not a heparin binding growth factor. D-54 MG cell line produced alpha 2-macroglobulin (alpha 2M), which is known to bind TGF beta; however, immunoprecipitation of alpha 2M did not deplete TGF beta or GDGF-2 activity. Further, neither GDGF-2 or TGF beta can be dissociated into lower molecular weight active components by chromatography in high salt (2 M NaCl) or 2-ME (0.5 M). GDGF-2 may be a novel autocrine or paracrine mitogen, stimulating mitotic division or interfering with normal cell growth regulation.
authors.affiliation: Brain Tumor Research Laboratories, University of Alabama at Birmingham 35294-0006.
authors.forename: E
authors.initials: E
authors.lastname: Lyon
authors.forename: G Y
authors.initials: GY
authors.lastname: Gillespie
mesh_terms: D001681:Biological Assay; D002850:Chromatography, Gel; D002852:Chromatography, Ion Exchange; D003470:Culture Media; D005910:Glioma / Q000503:physiopathology*; D006133:Growth Substances / Q000276:immunology / Q000302:isolation & purification* / Q000494:pharmacology; D006801:Humans; D007525:Isoelectric Focusing; D008934:Mitogens / Q000276:immunology / Q000302:isolation & purification* / Q000494:pharmacology; D009500:Neutralization Tests; D014407:Tumor Cells, Cultured
chemical_list: D003470:Culture Media; D006133:Growth Substances; D008934:Mitogens